Le Lézard
Classified in: Health
Subjects: TDS, FVT

Dr. David Amron M.D., Founder of The Roxbury Institute and Global Pioneer in Lipedema Treatment, to Speak at Fat Disorders Research Society Conference Saturday, April 28, 2018 in Dallas, Texas


BEVERLY HILLS, Calif., April 26, 2018 /PRNewswire/ -- For the 4th year, Dr. David Amron M.D. will be a featured speaker at the Fat Disorders Research Society Conference leading the Comprehensive Review of Science, Safety & Efficacy for Lipedema/Dercum's Surgery panel and break out sessions highlighting the advances in surgical treatment options for lipedema.  FDRS, founded in 2009, is an organization dedicated to investment in comprehensive research, collaboration, management advocacy and care to improve the lives of those with fat disorders. Their annual conference is the most important global convergence for practitioners and patients on fat-related diseases.

"Although first named in the 1940's, the crucial issue with lipedema has been the poorly understood disease biology, for which patients have historically had limited treatment options in terms of diagnostics, effective treatment protocols or long-term care to relieve their symptoms and eliminate the health and wellness issues associated with this chronic disease, making the FDRS conference and their work vitally important," said Dr. Amron.

After over a dozen years working on the most difficult cases gaining a masterful understanding of the disease biology and the combination of holistic and surgical protocols to serve the lipedema community, Dr. Amron dedicated his personal practice to concentrate on lipedema patient care, and has performed more than 2,000 lipedema surgeries.  The Roxbury Institute is now one of the world's most comprehensive centers for not only surgical but pre- and post-operative care as well as ongoing treatment planning.  

A patient advocate, Dr. Amron created the Lipedema Society to encourage public advocacy, awareness, education, support and resources for those affected by lipedema.  The Lipedema Society also sponsors a fellowship program to train qualified surgeons from around the world in lipedema surgery.  His protocols and programs will be presented at the FDRS Conference.

According to Dr. Amron, "Integrated albeit modified forms of advanced liposuction to remove the diseased fat is the best treatment available and starts a healing cascade.  We identify and remove the diseased fat from the patient relieving pain and increasing mobility, but as a result, the body then restores metabolic, hormonal and endocrine systems towards normalcy, giving the patient a chance to systematically normalize and heal physically, mentally and emotionally."

An estimated 17 million women in the U.S. alone suffer from this often debilitating, painful and life-threatening syndrome as well the isolation, depression, and stigma of the disease.

Annually the FDRS conference brings together the world's top physicians, clinicians, researchers, nutritionists and patients with compression and lymphatic drainage experts as well as hormone, fitness and inflammation specialists to educate the medical community as well as patients and caregivers to increase awareness of lipedema, Dercums Disease and other related fat disorders.

For more information please visit https://www.fatdisorders.org.
For more information on Dr. David Amron and the Roxbury institute please visit https://www.theroxburyinstitute.com/

To attend the conference or for more information, feel free to reach out to:
Media Contact: Jill Eistenstadt [email protected] 310.201.8222

About the Roxbury Institute:
Founded by Dr. David Amron a top dermatologic surgeon, liposculpture and body contouring expert and a lipedema treatment pioneer, the Roxbury Institute offers a world class diagnostic, medical treatment, and educational facility along with comprehensive services in state-of-the-art anti-aging and non-invasive cosmetic aesthetics, plastic surgery, naturopathy and regenerative care. Located in Beverly Hills, the Roxbury Institute offers the most extensive treatment protocols for patient care in an exceptional facility. Dr. Amron recently established the Advanced Lipedema Treatment Program at The The Roxbury Institute which is a comprehensive program that addresses all critical areas of lipedema treatment and involves a range of services including diagnosis, medical therapy, nutritional counseling, MLD/decongestive therapy, stem cell therapy, lymphatic sparing liposuction, plastic and reconstructive surgery, and pre/post surgical IV therapy.  The Roxbury Institute is also the home to a first-of-its-kind lipedema surgical fellowship program focusing on teaching the surgical methods for treatment and ongoing care. Regarded globally for standards of excellence, the Roxbury Institute, founder Dr. David Amron and his leading practitioners have been featured on the Doctors, ABC, FOX, NPR, The Huffington Post, Today and more.

 

SOURCE Roxbury Institute


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: